FDG PET correlates weakly with HIF-1α expression in solid tumors: a meta-analysis

Area of Science:

• Oncology
• Nuclear Medicine
• Molecular Imaging

Background:

• Hypoxia-inducible factor (HIF)-1α is crucial for tumor cell adaptation to hypoxia and is linked to aggressive cancers.
• 18F-FDG PET is a common imaging technique, but its correlation with HIF-1α expression in solid tumors is debated.

Purpose of the Study:

• To investigate the association between 18F-FDG PET's maximum standardized uptake value (SUVmax) and HIF-1α expression in solid tumors.
• To provide evidence-based data on the utility of FDG PET in reflecting tumor hypoxia.

Main Methods:

• A systematic literature review of MEDLINE, SCOPUS, and EMBASE databases was conducted up to August 2019.
• 21 studies involving 1154 patients were analyzed to extract correlation coefficients between SUVmax and HIF-1α expression.
• Subgroup analyses were performed for specific tumor types, including head and neck squamous cell carcinoma, non-small cell lung cancer, uterine cervical cancer, and thymic tumors.

Main Results:

• The overall pooled correlation coefficient between SUVmax and HIF-1α expression was weak (0.27).
• Individual tumor subgroup analyses also revealed weak correlations, with coefficients ranging from -0.09 to 0.39.
• The range of correlation coefficients across all studies was -0.51 to 0.71, indicating considerable variability.

Conclusions:

• 18F-FDG PET SUVmax demonstrates a weak correlation with HIF-1α expression in solid tumors overall and in specific subgroups.
• FDG PET is not a reliable method for predicting tumor hypoxia in clinical practice.
• Further research may be needed to explore alternative imaging biomarkers for tumor hypoxia.